SS
ANVS icon

SBI Securities’s Annovis Bio ANVS Stock Holding History

SBI Securities’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88K Buy
1,547
+25
+2% +$49 ﹤0.01% 2415
2026
Q1 		$3.39K Sell
1,522
-5
-0.3% -$14 ﹤0.01% 2203
2025
Q4 		$5.28K Buy
1,527
+96
+7% +$289 ﹤0.01% 1993
2025
Q3 		$2.96K Sell
1,431
-32
-2% -$80 ﹤0.01% 2265
2025
Q2 		$3.17K Buy
1,463
+23
+2% +$45 ﹤0.01% 2195
2025
Q1 		$2.16K Buy
1,440
+1,037
+257% +$3.17K ﹤0.01% 2258
2024
Q4 		$2.03K Buy
+403
New +$2.92K ﹤0.01% 2316

Other funds holding ANVS

FNT
First National Trust Hermitage, Pennsylvania $2.95B AUM 27.19% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $102M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
QWM
Quadcap Wealth Management Frisco, Texas $1.03B AUM 28.22% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

SBI Securities's ANVS Position: Q2 2026 in Review

SBI Securities increased its Annovis Bio (ANVS) stake by 1.6% in Q2 2026, buying an estimated $49 and bringing the position to 1,547 shares worth $2.88K. The position accounts for ﹤0.01% of the portfolio, ranked #2415.

SBI Securities first reported a position in ANVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.28K in Q4 2025. 13 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • SBI Securities held 1,547 shares of Annovis Bio worth $2.88K as of Q2 2026.
  • SBI Securities bought 25 Annovis Bio shares in Q2 2026, an estimated $49.
  • Annovis Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2415 holding.
  • SBI Securities first reported a position in Annovis Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Annovis Bio position peaked at $5.28K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.